Burjeel Holdings Reports Record Q3’25 Revenue Along With 27.5% Net Profit Growth
Burjeel Holdings Reports 129% Increase Q2’25 Net Profit, with Accelerated Revenue Growth
H.H. Sheikha Shaikha bint Saif bin Mohamed Al Nahyan Inaugurates New Thalassemia & Sickle Cell Center at Burjeel Medical City
AD Ports Group and Burjeel Holdings to Explore a JV to Optimise Healthcare Logistics in Africa
Burjeel Holdings Advances ESG Agenda with ‘Growing a Greener Tomorrow’ Initiative
A Year of Breakthroughs Beyond Borders: Explore Burjeel Holdings’ 2025 Milestones in Our Special Edition
Burjeel Investigators Contribute to USFDA Approval of First Oral Therapy for Anemia in Alpha- and Beta-Thalassemia
Burjeel Holdings Announces Board-Approved CEO Appointment
Burjeel Holdings announces 120 Health Ambassadors for the Year of Family Ahead of the 54th Eid Al Etihad
Burjeel Holdings Secures Two Wins at Emirates Labour Market Award
Burjeel Cancer Institute’s Breast Cancer Clinical Care Program Earns JCI Gold Certification
Building a Smarter, Healthier Future: Discover Burjeel Holdings’ October Milestones in Feat Focus
Global Experts Unite in Abu Dhabi to Shape the Future of Pediatric Bone Marrow Transplantation and Gene Therapy
